{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:57:09Z","timestamp":1769821029815,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jacl.2020.12.002","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T19:44:15Z","timestamp":1607715855000},"page":"320-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)"],"prefix":"10.1016","volume":"15","author":[{"given":"Jan Hoong","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-1897","authenticated-orcid":false,"given":"Safwaan","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4764-8536","authenticated-orcid":false,"given":"Yifen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shazli","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaishav","family":"Dhage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akheel A.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-4004","authenticated-orcid":false,"given":"Basil J.","family":"Ammori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle","family":"Donn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-4050","authenticated-orcid":false,"given":"Adrian","family":"Heald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-8903","authenticated-orcid":false,"given":"Rayaz A.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul N.","family":"Durrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handrean","family":"Soran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2020.12.002_bib1","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2020.12.002_bib2","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3390\/ijms12053117","article-title":"Inflammation, oxidative stress, and obesity","volume":"12","author":"Fernandez-Sanchez","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2020.12.002_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jacl.2020.12.002_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomark Med"},{"key":"10.1016\/j.jacl.2020.12.002_bib5","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1194\/jlr.M015776","article-title":"Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study","volume":"52","author":"Ravandi","year":"2011","journal-title":"J Lipid Res"},{"issue":"Suppl","key":"10.1016\/j.jacl.2020.12.002_bib6","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1194\/jlr.R800074-JLR200","article-title":"The role of oxidized phospholipids in atherosclerosis","volume":"50","author":"Berliner","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.12.002_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2020.12.002_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","article-title":"Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes","volume":"41","author":"Tsimikas","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib9","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","article-title":"Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein","volume":"109","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2020.12.002_bib10","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1194\/jlr.M040733","article-title":"Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)","volume":"54","author":"Leibundgut","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.12.002_bib11","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race\/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study","volume":"119","author":"Tsimikas","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2020.12.002_bib12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.168.6.598","article-title":"Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data","volume":"168","author":"Bennet","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2020.12.002_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Emerging Risk Factors","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2020.12.002_bib14","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/eurheartj\/ehx166","article-title":"Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium","volume":"38","author":"Waldeyer","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2020.12.002_bib15","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.12.002_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOL.0000000000000096","article-title":"Lipoprotein (a): gene genie","volume":"25","author":"Durrington","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2020.12.002_bib17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib18","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2013.12.030","article-title":"Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a)","volume":"63","author":"Tsimikas","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.metabol.2014.08.007","article-title":"Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients","volume":"63","author":"Marzano","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2020.12.002_bib20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/01.ATV.18.8.1335","article-title":"Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype","volume":"18","author":"Rainwater","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2020.12.002_bib21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.17.10.1135","article-title":"The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men","volume":"17","author":"Duell","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2020.12.002_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00125-017-4246-y","article-title":"Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes","volume":"60","author":"Berk","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2020.12.002_bib23","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1194\/jlr.M005769","article-title":"Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet","volume":"51","author":"Faghihnia","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.12.002_bib24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/01.ATV.0000118012.64932.f4","article-title":"Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a)","volume":"24","author":"Silaste","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2020.12.002_bib25","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fimmu.2017.01512","article-title":"Effect of roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes","volume":"8","author":"Yadav","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacl.2020.12.002_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1479164119826479","article-title":"Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: small, dense low-density lipoprotein and interleukin-6","volume":"16","author":"Adam","year":"2019","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacl.2020.12.002_bib27","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","article-title":"Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes","volume":"370","author":"Schauer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2020.12.002_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sjostrom","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2020.12.002_bib29","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1136\/heartjnl-2012-301778","article-title":"Bariatric surgery and cardiovascular outcomes: a systematic review","volume":"98","author":"Vest","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jacl.2020.12.002_bib30","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/eurheartj\/ehaa069","article-title":"Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study","volume":"41","author":"Moussa","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2020.12.002_bib31","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2013.02.047","article-title":"Oxidation-specific biomarkers and risk of peripheral artery disease","volume":"61","author":"Bertoia","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jacl.2018.02.014","article-title":"Relationship between \"LDL-C\", estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide","volume":"12","author":"Viney","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2020.12.002_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2020.12.002_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2020.12.002_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jacc.2011.12.033","article-title":"Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction","volume":"59","author":"Leibundgut","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib36","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1194\/jlr.P027235","article-title":"Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia","volume":"53","author":"Arai","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.12.002_bib37","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","article-title":"Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib38","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","article-title":"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib39","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.12.047","article-title":"Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin","volume":"47","author":"Rodenburg","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib40","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.107.145805","article-title":"Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study","volume":"27","author":"Kiechl","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2020.12.002_bib41","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jacc.2010.04.048","article-title":"Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events","volume":"56","author":"Tsimikas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib42","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/01.CIR.0000141728.23033.B5","article-title":"High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial","volume":"110","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2020.12.002_bib43","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.12.002_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2020.02.026","article-title":"Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor","volume":"299","author":"Konishi","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2020.12.002_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0021-9150(94)90109-0","article-title":"Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia","volume":"108","author":"Bartens","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2020.12.002_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0021-9150(93)90117-D","article-title":"Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population","volume":"101","author":"Werba","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2020.12.002_bib47","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/diacare.24.2.350","article-title":"Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients","volume":"24","author":"Hernandez","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2020.12.002_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s001250051110","article-title":"Insulin suppresses apolipoprotein(a) synthesis by primary cultures of cynomolgus monkey hepatocytes","volume":"42","author":"Neele","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2020.12.002_bib49","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2020.12.002_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cmet.2019.10.014","article-title":"Neutralization of oxidized phospholipids ameliorates non-alcoholic steatohepatitis","volume":"31","author":"Sun","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacl.2020.12.002_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2020.12.002_bib52","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jacc.2015.01.050","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial","volume":"65","author":"Byun","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacc.2016.10.057","article-title":"Oxidized phospholipids on apolipoprotein B-100 and recurrent ischemic events following stroke or transient ischemic attack","volume":"69","author":"Byun","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib54","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/ATVBAHA.116.308761","article-title":"Oxidized phospholipids and risk of calcific aortic valve disease: the copenhagen general population study","volume":"37","author":"Kamstrup","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2020.12.002_bib55","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2020.12.002_bib57","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacl.2016.01.005","article-title":"Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a)","volume":"10","author":"Yeang","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2020.12.002_bib58","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","article-title":"Statin therapy increases lipoprotein(a) levels","volume":"41","author":"Tsimikas","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2020.12.002_bib59","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2008.01.026","article-title":"The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans","volume":"51","author":"Ky","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2020.12.002_bib60","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0038-1650639","article-title":"Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure","volume":"76","author":"Holvoet","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacl.2020.12.002_bib61","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1194\/jlr.M600109-JLR200","article-title":"Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia","volume":"47","author":"Tsouli","year":"2006","journal-title":"J Lipid Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287420303391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287420303391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:36:11Z","timestamp":1761831371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287420303391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1933287420303391"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2020.12.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}